| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.09B | — | +19.5% |
| Cost of Revenue | $802.0M | — | +10.9% |
| Gross Profit | $2.29B | — | +22.8% |
| R&D Expense | $450.0M | — | +24.3% |
| SG&A Expense | $410.0M | — | +57.1% |
| Operating Income | $611.0M | — | -0.8% |
| Pre-tax Income | $618.0M | — | -2.5% |
| Income Tax | $106.0M | — | -17.8% |
| Net Income | $512.0M | — | +1.8% |
| EPS (Basic) | $1.14 | — | +5.6% |
| EPS (Diluted) | $1.12 | — | +5.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.89B | +55.0% | -4.5% |
| Accounts Receivable | $152.0M | +12.6% | +40.7% |
| Current Assets | $6.26B | +23.1% | -8.9% |
| Total Assets | $17.89B | +1.6% | -5.6% |
| Current Liabilities | $5.13B | +10.7% | -12.7% |
| Long-term Debt | $5.99B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $969.0M | — | +28.3% |
| Capital Expenditures | $72.0M | — | -49.7% |
| Investing Cash Flow | $783.0M | — | -40.3% |
| Financing Cash Flow | -$561.0M | — | +55.0% |
| Free Cash Flow | $897.0M | — | +46.6% |
| +4.2% |
| Total Liabilities | $13.48B | +3.7% | -3.7% |
| Stockholders' Equity | $4.41B | -4.4% | -10.9% |